Evidence map›Paper›PMID 32973518›Full record

ArticleFrontiers in pharmacology2020

Effects of Different Doses of Eucalyptus Oil From

Jie Shao, Zhenjie Yin, Yaqin Wang, Yudong Yang, Qing Tang, Mingming Zhang, Jieying Jiao, Chengjie Liu, Mingfang Yang, Lifang Zhen and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. Frontiers in veterinary science · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Combination of Chemically-Characterized Essential Oils fromAdvances in pharmacological and pharmaceutical sciences · 2023
    Article
  10. Essential Oils and COVID-19.Molecules (Basel, Switzerland) · 2022
    Review
  11. Article
  12. Essential Oil fromMolecules (Basel, Switzerland) · 2022
    Article
  13. Article
  14. Antiviral Activities ofPharmaceuticals (Basel, Switzerland) · 2021
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Jie Shao521 Hospital of Norinco Group, Xi'an, China.
Zhenjie Yin521 Hospital of Norinco Group, Xi'an, China.
Yaqin Wang521 Hospital of Norinco Group, Xi'an, China.
Yudong Yang521 Hospital of Norinco Group, Xi'an, China.
Qing Tang521 Hospital of Norinco Group, Xi'an, China.
Mingming Zhang521 Hospital of Norinco Group, Xi'an, China.
Jieying Jiao521 Hospital of Norinco Group, Xi'an, China.
Chengjie Liu521 Hospital of Norinco Group, Xi'an, China.
Mingfang Yang521 Hospital of Norinco Group, Xi'an, China.
Lifang Zhen521 Hospital of Norinco Group, Xi'an, China.
Amira HassounaSchool of Public Health and Interdisciplinary Studies, Faculty of Health and Environmental Sciences, Auckland University of Technology, Auckland, New Zealand.
William Lindsey WhiteSchool of Science, Faculty of Health and Environmental Sciences, Auckland University of Technology, Auckland, New Zealand.
Jun LuSchool of Public Health and Interdisciplinary Studies, Faculty of Health and Environmental Sciences, Auckland University of Technology, Auckland, New Zealand.
China North Industries Group Corporation (China) · CNAuckland University of Technology · NZCairo University · EGMaurice Wilkins Centre · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Eucalyptol (1,8-cineole), the major constituent of eucalyptus oil (EO), was used in traditional medicine as a remedy for colds and bronchitis. This study aimed at clarifying the effect of eucalyptol on respiratory immune function of CD8 and CD4 cells, and alveolar macrophages (AM). Thirty male Sprague-Dawley rats were divided into experimental and control groups. The drug was given once a day for 3 weeks and the experimental group was divided according to the eucalyptol dose into: 30, 100, and 300 mg·kg

Indexed as

CD4/CD8eucalyptolimmunityimmunoglobulinsmacrophagesNK cellsrespiratory tractT/B cells

Identifiers

PMID32973518
PMCPMC7472567
OpenAlexW3080290558

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.